Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Aug;89(8):854-8.
doi: 10.1136/heart.89.8.854.

Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure

A S Androne  1 , K Hryniewicz, R Goldsmith, A Arwady, S D Katz
Affiliations
Clinical Trial

Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure

A S Androne et al. Heart. 2003 Aug.

Abstract

Objective: To characterise the effects of acetylcholinesterase inhibition with pyridostigmine on parasympathetic tone in patients with chronic heart failure (CHF).

Design: Prospective randomised, double blind crossover trial.

Setting: University hospital outpatient heart failure clinic.

Patients: 20 ambulatory subjects with stable CHF (mean age 55 years, mean ejection fraction 24%).

Interventions: Oral administration of a single dose of pyridostigmine 30 mg and matching placebo on separate days.

Main outcome measures: Heart rate recovery at one minute and three minutes after completion of maximal exercise.

Results: Heart rate recovery at one minute after exercise was significantly greater after administration of pyridostigmine than after administration of placebo (mean (SEM) 27.4 (3.2) beats/min v 22.4 (2.4) beats/min, p < 0.01). Heart rate recovery at three minutes after exercise did not differ after administration of pyridostigmine and placebo (mean (SEM) 44.4 (3.9) beats/min v 41.8 (3.6) beats/min, NS). Peak heart rate, peak oxygen uptake, peak respiratory exchange ratio, plasma noradrenaline (norepinephrine) concentrations, and plasma brain natriuretic peptide concentrations did not differ after administration of pyridostigmine and placebo.

Conclusions: Acetylcholinesterase inhibition with pyridostigmine increased heart rate recovery at one minute but not at three minutes after exercise. A specific effect of pyridostigmine on heart rate one minute after exercise suggests that pyridostigmine augments parasympathetic tone in patients with CHF.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Heart rate recovery (HRR, beats/min, mean with error bar indicating positive SEM) at one minute and three minutes after maximal exercise in 20 subjects with chronic heart failure after treatment with pyridostigmine (solid bars) or placebo (open bars). *p<0.01 v placebo.
See this image and copyright information in PMC

References

    1. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248–54. - PubMed
    1. Rosenwinkel ET, Bloomfield DM, Arwady MA, et al. Exercise and autonomic function in health and cardiovascular disease. Cardiol Clin 2001;19:369–87. - PubMed
    1. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819–23. - PubMed
    1. Binkley PF, Nunziata E, Haas GJ, et al. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991;18:464–72. - PubMed
    1. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 1971;285:877–83. - PubMed

Publication types

Substances